Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
CLOV logo CLOV
Upturn stock ratingUpturn stock rating
CLOV logo

Clover Health Investments Corp (CLOV)

Upturn stock ratingUpturn stock rating
$3.38
Delayed price
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

04/22/2025: CLOV (5-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

ratingratingratingratingrating

Outstanding Performance

These Stocks/ETFs, based on Upturn Advisory, have historically outperformed the market, making them a top-tier choice for investors.

Analysis of Past Performance

Type Stock
Historic Profit 116.8%
Avg. Invested days 32
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 3.0
Stock Returns Performance Upturn Returns Performance 5.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 04/22/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 1.84B USD
Price to earnings Ratio -
1Y Target Price 4.75
Price to earnings Ratio -
1Y Target Price 4.75
Volume (30-day avg) 5646453
Beta 2
52 Weeks Range 0.63 - 4.87
Updated Date 04/22/2025
52 Weeks Range 0.63 - 4.87
Updated Date 04/22/2025
Dividends yield (FY) -
Basic EPS (TTM) -0.09

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -3.14%
Operating Margin (TTM) -6.37%

Management Effectiveness

Return on Assets (TTM) -4.99%
Return on Equity (TTM) -14.75%

Valuation

Trailing PE -
Forward PE -
Enterprise Value 1366824269
Price to Sales(TTM) 1.34
Enterprise Value 1366824269
Price to Sales(TTM) 1.34
Enterprise Value to Revenue 1
Enterprise Value to EBITDA -0.65
Shares Outstanding 418532000
Shares Floating 401342764
Shares Outstanding 418532000
Shares Floating 401342764
Percent Insiders 4.99
Percent Institutions 22.48

Analyst Ratings

Rating 4
Target Price 4.75
Buy -
Strong Buy 2
Buy -
Strong Buy 2
Hold 2
Sell -
Strong Sell -
Strong Sell -

ai summary icon Upturn AI SWOT

Clover Health Investments Corp

stock logo

Company Overview

overview logo History and Background

Clover Health Investments Corp. was founded in 2014 with the mission to improve healthcare outcomes, particularly for seniors. It went public via a SPAC merger with Social Capital Hedosophia Holdings Corp. III in January 2021.

business area logo Core Business Areas

  • Medicare Advantage Plans: Clover Health offers Medicare Advantage (MA) plans to eligible beneficiaries, focusing on technology-driven care management to improve health outcomes.
  • Clover Assistant: Clover Assistant is a software platform provided to physicians, leveraging data and machine learning to offer personalized care recommendations and streamline administrative tasks.

leadership logo Leadership and Structure

Andrew Toy is the Chief Executive Officer. The company has a board of directors overseeing its operations.

Top Products and Market Share

overview logo Key Offerings

  • Medicare Advantage Plans: Clover Health provides Medicare Advantage plans, primarily targeting underserved communities. Market share information is difficult to precisely determine, but Clover Health operates in specific geographic markets and competes with larger national players. Competitors include UnitedHealth Group, Humana, and CVS Health (Aetna).
  • Clover Assistant: Clover Assistant is a technology platform offered to primary care physicians to improve patient care and practice management. No specific market share data is publicly available. Its success is tied to physician adoption. Competitors include other EHR systems and practice management software vendors.

Market Dynamics

industry overview logo Industry Overview

The healthcare industry is experiencing significant growth, driven by an aging population and rising healthcare costs. Technological innovation and value-based care models are increasingly important.

Positioning

Clover Health positions itself as a technology-driven healthcare company focused on improving outcomes for Medicare Advantage members, particularly those in underserved communities. It competes with larger, established players.

Total Addressable Market (TAM)

The Medicare Advantage market is estimated to be hundreds of billions of dollars. Clover Health is focused on capturing a larger share of this market by leveraging its technology platform to improve care quality and efficiency.

Upturn SWOT Analysis

Strengths

  • Technology-driven platform (Clover Assistant)
  • Focus on underserved communities
  • Potential for improved healthcare outcomes through data analysis
  • Strong relationships with physicians in some markets

Weaknesses

  • Relatively small market share compared to major players
  • Dependence on Medicare Advantage regulations
  • History of financial losses
  • Concentration in specific geographic markets

Opportunities

  • Expansion into new geographic markets
  • Increased adoption of Clover Assistant by physicians
  • Partnerships with healthcare providers and organizations
  • Growing Medicare Advantage market

Threats

  • Intense competition from larger, well-established healthcare companies
  • Changes in Medicare Advantage regulations
  • Rising healthcare costs
  • Adverse selection in Medicare Advantage plans

Competitors and Market Share

competitor logo Key Competitors

  • UNH
  • HUM
  • CVS
  • CI
  • MOH

Competitive Landscape

Clover Health faces significant competition from larger, more established healthcare companies. Its competitive advantage lies in its technology platform and focus on underserved communities, but it needs to scale its operations and achieve profitability to compete effectively.

Major Acquisitions

Growth Trajectory and Initiatives

Historical Growth: Clover Health has experienced revenue growth in recent years, but it has also faced significant financial losses.

Future Projections: Analyst estimates for Clover Health's future growth vary, with projections for continued revenue growth but uncertainty regarding profitability.

Recent Initiatives: Recent initiatives include expanding its geographic footprint, enhancing its Clover Assistant platform, and focusing on improving care quality.

Summary

Clover Health is a technology-driven healthcare company focused on the Medicare Advantage market. While it possesses a unique technology platform and targets underserved communities, it faces intense competition and has a history of financial losses. Future success depends on expanding its market share, achieving profitability, and navigating the evolving regulatory landscape. Investor should look out for changing regulations.

Similar Companies

AMZNratingrating

Amazon.com Inc

$196.59
Large-Cap Stock
0%
PASS

AMZNratingrating

Amazon.com Inc

$196.59
Large-Cap Stock
0%
PASS

CIratingrating

Cigna Corp

$337.07
Large-Cap Stock
7.91%
Consider higher Upturn Star rating
BUY since 40 days

CIratingrating

Cigna Corp

$337.07
Large-Cap Stock
BUY since 40 days
7.91%
Consider higher Upturn Star rating

CVSratingrating

CVS Health Corp

$65.23
Large-Cap Stock
14.64%
Consider higher Upturn Star rating
BUY since 28 days

CVSratingrating

CVS Health Corp

$65.23
Large-Cap Stock
BUY since 28 days
14.64%
Consider higher Upturn Star rating

GOOGratingrating

Alphabet Inc Class C

$153.9
Large-Cap Stock
0%
PASS

GOOGratingrating

Alphabet Inc Class C

$153.9
Large-Cap Stock
0%
PASS

HUMratingrating

Humana Inc

$258.92
Large-Cap Stock
-12.24%
WEAK BUY
BUY since 7 days

HUMratingrating

Humana Inc

$258.92
Large-Cap Stock
BUY since 7 days
-12.24%
WEAK BUY

MOHratingrating

Molina Healthcare Inc

$321.16
Large-Cap Stock
-1.88%
WEAK BUY
BUY since 32 days

MOHratingrating

Molina Healthcare Inc

$321.16
Large-Cap Stock
BUY since 32 days
-1.88%
WEAK BUY

UNHratingrating

UnitedHealth Group Incorporated

$427.18
Large-Cap Stock
-18.34%
WEAK BUY
BUY since 15 days

UNHratingrating

UnitedHealth Group Incorporated

$427.18
Large-Cap Stock
BUY since 15 days
-18.34%
WEAK BUY

Sources and Disclaimers

Data Sources:

  • Company filings
  • Analyst reports
  • Industry publications

Disclaimers:

This analysis is for informational purposes only and should not be considered financial advice. Market share data is based on available estimates and may not be precise.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Clover Health Investments Corp

Exchange NASDAQ
Headquaters Wilmington, DE, United States
IPO Launch date 2001-01-02
Co-Founder, CEO & Director Mr. Andrew Toy
Sector Healthcare
Industry Healthcare Plans
Full time employees 570
Full time employees 570

Clover Health Investments, Corp. provides medicare advantage plans in the United States. The company offers preferred provider organization and health maintenance organization plans to medicare-eligible individuals. It operates Clover Assistant, a software platform to execute strategy by enabling physicians to detect, identify, and manage chronic diseases earlier than they otherwise could. The company is based in Wilmington, Delaware.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​